Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $66

Benzinga · 9h ago
Citigroup analyst Yigal Nochomovitz maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $65 to $66.